The AS1517499 is a well-known potent and selective STAT6 inhibitor [45], and we proved here the critical role of STAT6 pathway, not only in the progression and development of cancer as previously reported [12], but also its synergistic activity when combined with 5-FU therapy in the already established colon cancer. Here, STAT6 is linked to malignant colon neoplasm.